A Taiwanese Nationwide Cohort Study Shows Interferon-Based Therapy for Chronic Hepatitis C Reduces the Risk of Chronic Kidney Disease
about
Risks of Adverse Events Following Coprescription of Statins and Calcium Channel Blockers: A Nationwide Population-Based StudyImpact of hepatitis C virus therapy on metabolism and public health.Chronic hepatitis C virus (HCV) increases the risk of chronic kidney disease (CKD) while effective HCV treatment decreases the incidence of CKD.Nationwide cohort study suggests that nucleos(t)ide analogue therapy decreases dialysis risk in Taiwanese chronic kidney disease patients acquiring hepatitis B virus infection.
P2860
A Taiwanese Nationwide Cohort Study Shows Interferon-Based Therapy for Chronic Hepatitis C Reduces the Risk of Chronic Kidney Disease
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A Taiwanese Nationwide Cohort ...... Risk of Chronic Kidney Disease
@ast
A Taiwanese Nationwide Cohort ...... Risk of Chronic Kidney Disease
@en
type
label
A Taiwanese Nationwide Cohort ...... Risk of Chronic Kidney Disease
@ast
A Taiwanese Nationwide Cohort ...... Risk of Chronic Kidney Disease
@en
prefLabel
A Taiwanese Nationwide Cohort ...... Risk of Chronic Kidney Disease
@ast
A Taiwanese Nationwide Cohort ...... Risk of Chronic Kidney Disease
@en
P2093
P2860
P1433
P1476
A Taiwanese Nationwide Cohort ...... Risk of Chronic Kidney Disease
@en
P2093
Chia-Pin Wu
Li-Chu Lin
Shang-Jyh Hwang
Yi-Chun Chen
P2860
P356
10.1097/MD.0000000000001334
P407
P50
P577
2015-08-01T00:00:00Z